header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

Trauma

SURGICAL TREATMENT OF THE FEMUR FOR METASTASES: AN ANALYSIS OF IMPLANT AND ONCOLOGICAL SURVIVAL COMPARING NAILING VERSUS PROSTHETIC REPLACEMENT

European Federation of National Associations of Orthopaedics and Traumatology (EFORT) - 12th Congress



Abstract

Aim

Aim of this study was to review surgical treatment of femural metastases, comparing nailing versus resection and prosthetic reconstruction.

Method

Between 1975 and 2008 110 patients were surgically treated for metastatic disease of the femur. Prostheses were implanted in 57 cases (16 HMRS® Stryker, 38 MRP® Bioimpianti, 2 Osteobridge® and 1 GMRS®). In 53 patients femoral nailing was performed with different types of locked nails (32 Gamma, 14 Grosse-Kempft and 6 T2-Stryker®). Sites of primary tumor were breast (33 cases), kidney (18), lung (17), undifferentiated carcinoma (14), g.i. (8), bladder and prostate (5 each), endometrium and thyroid (3 each), skin (2), pheochromocytoma and pancreas (1 each). Indications to nails were given in patients with femoral metastasis and poor prognosis: multiple metastases, short free interval, unfavourable histotype, poor general conditions. Resection and prosthesis was preferred for patients with solitary metastasis, long free interval, favourable histotype, good general conditions or in whenever the extent of the lesion was not amenable to a durable internal fixation. Complications were analysed. Univariate analysis by Kaplan-Meier curves of implant and oncological survival was performed. Functional results were assessed with MSTS system.

Results

Outcome showed: 23 AWD at mean 52 months, 57 DWD at mean 9 months, 30 lost to follow up. Survival in patients treated with femoral nailing was about 10% at 5 years versus 20% for patients treated with resection. Patients with resections had a better survival curve at 2 years. Complications were: infections (4/110, 3.7%), aseptic loosening (1/110, 1%). Statistical analysis showed a significantly better survival for patients resected versus those treated by internal fixation (p=0.0214). Multivariate analysis indicated that pathologic fracture is the only significant adverse prognostic factor (p=0.006).

Conclusion

Internal fixation is indicated in patients with multiple metastases and poor prognosis. When expected survival is longer and there is a solitary metastasis a resection is preferable. Indications of resections are progressively increasing due to newer medical treatment giving longer survival to metastatic patients.